In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (11) , 608-612
- https://doi.org/10.1046/j.1469-0691.2000.00152.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antibiotic resistance in Gram-positive bacteria: epidemiological aspectsJournal of Antimicrobial Chemotherapy, 1999
- Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolatesThe American Journal of Medicine, 1998
- Multidrug Resistance — A Sign of the TimesNew England Journal of Medicine, 1998
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristinJournal of Antimicrobial Chemotherapy, 1997
- A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmasJournal of Antimicrobial Chemotherapy, 1997
- Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristinJournal of Antimicrobial Chemotherapy, 1997
- In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC of the components of a semisynthetic streptogramin, RP 59500Journal of Antimicrobial Chemotherapy, 1992
- The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combinationJournal of Antimicrobial Chemotherapy, 1992
- Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compoundsJournal of Antimicrobial Chemotherapy, 1992